PEDIATRICS

June 16, 2022

Prior Pediatric COVID-19 Infections and Low Omicron Immunity Linked

June 16, 2022

FDA Approves Dupixent for Pediatric Patients With Moderate-to-Severe Atopic Dermatitis

June 16, 2022

Positive Results Reported From Phase II/III Rylaze Trial

May 4, 2022

Higher Relapse Risk in Latino Pediatric Patients With ALL

May 4, 2022

COVID-19 Treatment Approved for Patients Aged Younger Than 12 Years

May 4, 2022

Impact of COVID-19 Pandemic on Pediatric Oncology Providers

April 18, 2022

Long-Acting HIV Injectable Therapy Approved for Adolescents

April 18, 2022

Jazz Pharmaceuticals Completes FDA sBLA for Rylaze Dosing Schedule

April 18, 2022

Jazz Pharmaceuticals Completes FDA sBLA for Rylaze Dosing Schedule

April 18, 2022

Program Provides Molecular Characterization of Pediatric Cancers

April 14, 2022

Maternal COVID-19 Infection and Neonatal Impact

January 14, 2022

Carbamazepine 25 mg/mL in SyrSpend SF PH4

January 14, 2022

ADD/ADHD Prevalence and Treatment in Children

June 2022

June 2022

In This Issue Digital Magazine Archives Subscription

Related CE

$6.97 Per CE Exam or $59 for 12 Lessons

Pediatric Food Allergy Update

View More CE

Copyright © 2000 - 2022 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.